Cytarabine Accord 100 mg/ml

DRUG2 trials

Sponsors

Princess Maxima Center For Pediatric Oncology, Janssen - Cilag International

Conditions

Acute Myeloid LeukemiaAcute lymphoblastic leukemia

Phase 1

A Phase 1b Study of Bleximenib in Combination with AML Directed Therapies for Participants with Acute Myeloid Leukemia Harboring KMT2A or NPM1 Alterations

Active, not recruitingCTIS2023-506582-58-00

Janssen - Cilag InternationalAcute Myeloid Leukemia

Start: 2022-07-21Target: 86Updated: 2025-10-03

Phase 3

Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia

SuspendedCTIS2022-502503-30-00

Princess Maxima Center For Pediatric OncologyAcute lymphoblastic leukemia

Start: 2022-12-15Target: 206Updated: 2026-01-27